Perivan welcomes Arecor Therapeutics plc to our Creative annual report portfolio
May 2025
Arecor Therapeutics plc is an AIM Listed, globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying their innovative proprietary technology platform, Arestat™, they are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products. The Arestat™ platform is supported by an extensive patent portfolio
Publication of Annual Report
Having printed the annual report for two years from supplied files, the Perivan Design and Shareholder Communications team were delighted to secure the design and typesetting elements this year.
The client brief was to have a light but interesting refresh to move things forward. The final visual choice was made from a number of creative options submitted and our 24hr typesetting enabled timing to stay on track to post out on schedule.
To view the annual report, click here.
Perivan is the UK’s leading designer and producer of annual reports. For further information, click here.
